| Metric | Q1 2025 | Q4 2024 | Q1 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $325M | — | $226M | — | 43.8% |
| Op. Income | $229M | — | $144M | — | 59.0% |
| Gross Margin | 86.2% | — | 97.8% | — | -11.6pp |
| Net Margin | 54.2% | — | 48.2% | — | 5.9pp |
| EPS (Diluted) | $3.44 | — | $1.89 | — | 82.0% |
| Free Cash Flow | $87M | — | -$74M | — | 217.6% |
| Item | Amount |
|---|---|
| REVENUE | $325M |
| Cost of Revenue | $45M |
| GROSS PROFIT | $280M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $60M |
| SG&A Expenses | $60M |
| Other Expenses | -$9M |
| Operating Expenses | $51M |
| Cost & Expenses | $96M |
| OPERATING INCOME | $229M |
| Interest Income | $0 |
| Interest Expense | $22M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $229M |
| Income Tax Expense | $44M |
| Net Income from Continuing Ops | $185M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $176M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $175M |
| D&A | $0 |
| EBIT | $251M |
| EBITDA | $251M |
| EPS | $3 |
| EPS Diluted | $3 |
| Item | Amount |
|---|---|
| REVENUE | $325M |
| Cost of Revenue | $45M |
| GROSS PROFIT | $280M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $60M |
| SG&A Expenses | $60M |
| Other Expenses | -$9M |
| Operating Expenses | $51M |
| Cost & Expenses | $96M |
| OPERATING INCOME | $229M |
| Interest Income | $0 |
| Interest Expense | $22M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $229M |
| Income Tax Expense | $44M |
| Net Income from Continuing Ops | $185M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $176M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $175M |
| D&A | $0 |
| EBIT | $251M |
| EBITDA | $251M |
| EPS | $3 |
| EPS Diluted | $3 |
| Item | Amount |
|---|---|
| Net Income | $176M |
| Depreciation & Amortization | $0 |
| Stock-Based Compensation | -$28M |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | -$61M |
| Change in Working Capital | $0 |
| OPERATING CASH FLOW | $87M |
| Capital Expenditure | $0 |
| Acquisitions (Net) | $0 |
| Purchases of Investments | -$359M |
| Sales/Maturities of Investments | $492M |
| Other Investing Activities | $1M |
| NET CASH FROM INVESTING | $134M |
| Net Debt Issuance | -$4M |
| Common Stock Repurchased | -$120M |
| Common Dividends Paid | -$19M |
| Other Financing Activities | -$27M |
| NET CASH FROM FINANCING | -$170M |
| FREE CASH FLOW | $87M |
| Net Change in Cash | $55M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $177M |
| Short-Term Investments | $2.3B |
| Net Receivables | $2.0B |
| Inventory | $0 |
| Other Current Assets | $3.9B |
| TOTAL CURRENT ASSETS | $8.2B |
| PP&E (Net) | $119M |
| Goodwill | $0 |
| Intangible Assets | $181M |
| Long-Term Investments | $6.6B |
| Tax Assets | $0 |
| Other Non-Current Assets | -$6.9B |
| TOTAL NON-CURRENT ASSETS | $0 |
| TOTAL ASSETS | $11.9B |
| Account Payables | $0 |
| Short-Term Debt | $0 |
| Deferred Revenue | $3.7B |
| Other Current Liabilities | $294M |
| TOTAL CURRENT LIABILITIES | $4.0B |
| Long-Term Debt | $1.7B |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $4.6B |
| TOTAL NON-CURRENT LIABILITIES | $6.3B |
| TOTAL LIABILITIES | $6.3B |
| Common Stock | $0 |
| Additional Paid-In Capital | $0 |
| Retained Earnings | $5.9B |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | -$314M |
| Other Equity | $1M |
| TOTAL STOCKHOLDERS' EQUITY | $5.6B |
| Minority Interest | $67M |
| TOTAL EQUITY | $5.7B |
| TOTAL LIABILITIES & EQUITY | $11.9B |
| Total Debt | $1.7B |
| Net Debt | $1.5B |
